Background Whether probiotics are beneficial at all stages of treatment in inflammatory
bowel disease or superior to placebo remains controversial. Methods Two reviewers …

Background Ulcerative colitis is an inflammatory condition affecting the colon, with an
annual incidence of approximately 10 to 20 per 100,000 people. The majority of people with …

Inflammatory bowel diseases (IBDs), namely Crohn's disease and ulcerative colitis, are
lifelong chronic disorders arising from interactions among genetic, immunological and …

Background Ulcerative colitis is an inflammatory condition affecting the colon, with an
annual incidence of approximately 10 to 20 per 100,000 people. The majority of people with …

Convincing evidence from both animal models and the study of patients with ulcerative
colitis (UC) implicates the intestinal microflora in the initiation and maintenance of the …

Background Ulcerative colitis (UC) and Crohn's disease (CD) are inflammatory bowel
diseases (IBD). Evidence implicates disturbances of the gastrointestinal microbiota in their …

abstract Inflammatory bowel disease (IBD) generally comprises Crohn's disease (CD) and
ulcerative colitis (UC), and their main characteristic is the intestinal mucosa inflammation …

Background & aims Clinical studies of using probiotics for managing ulcerative colitis (UC)
in Jordan are rare. Therefore, we aimed to evaluate the effect of probiotic supplementation …

It has been presumed that aberrant immune response to intestinal microorganisms in
genetically predisposed individuals may play a major role in the pathogenesis of the …

Probiotics, for the treatment of inflammatory bowel disease, are a group of specific
nonpathogenic bacteria that are functionally and genetically defined by their ability to reduce …